Seegene
Anyplextm System
Multiplex Real-time PCR with READ™ technology
Technology
Seegene's innovative real-time PCR method, READ™ (REal Amplicon Detection), is a powerful technology that overcomes the limitations of conventional real-time PCR. READ™ is totally different from current probe- (TaqMan, Molecular Beacon, etc.) and primer-based (Scorpion, LUX, Sunrise, etc.) real-time PCR methods, and opens new opportunities for highly effective pathogen detection.
Anyplex™ FluA/B Typing Real-time Detection
Anyplex™ FluA/New H1N1 Real-time Detection
Anyplex™ MTB/NTM Real-time Detection
Anyplex™ CT/NG Real-time Detection
Anyplex™ BRAF V600E Real-time Detection
Anyplex™ VanR Real-time Detection
Anyplex™ CMV Real-time Quantitation
Anyplex™ II RV16 Detection
Anyplex™ II STI-7 Detection
Anyplex™ Plus MTB/NTM Detection
Anyplex™ Plus MDR-TB Detection
Anyplex™ Applications Overview |
[PDF 10KB] |
Anyplex™ Catalogue |
[PDF 11000KB] |
Anyplex™ New Products Catalogue |
[PDF 4800KB] |
Anyplex™ Flu A/B Typing |
[PDF 1090KB] |
Anyplex™ II RV16 Detection |
[PDF 1930KB] |
Anyplex™ II STI-7Detection |
[PDF 1830KB] |
Anyplex™ Plus MTB/NTM/DR-TB |
[PDF 1560KB] |
READ™ Technology |
[PDF 960KB] |
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
| Your local distributor Order About us Job opportunities |
Search
News
The recently launched EntroGen BRAF (V600E/K/D) test, that can be run on your real-time PCR instrument, is now CE-IVD marked
The EntroGen BRAF (V600E/K/D) test is a very useful tool for the detection of important mutations found in melanoma, because it detects, beside the V600E more
INFINITI KRAS-BRAF study from the Basel Institut of Pathology published in the Diagnostic Molecular Pathology journal.
New publication about the INFINITI KRAS assay in the Journal Diagn Mol Path 21/1 2012 14-23, Bihl et al. In this study from the Institute of Pathology at more
Recent publications on BÜHLMANN calprotectin assays
Three very interesting new papers have been published recently. Manz et al. describes the quality and usefulness of the BÜHLMANN calprotectin ELISA in an more
NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND
BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |